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A B S T R A C T   
Brachyury is an embryonic nuclear transcription factor required for mesoderm formation and differentiation. Here, we introduced an mCherry reporter into the C- 
terminus of Brachyury in the human pluripotent stem cell line SNUhES3 using the CRISPR/Cas9 nuclease approach. Successful gene editing was verified by DNA 
sequencing. SNUhES3-Brachyury-mCherry cells expressed pluripotent stem cell markers, exhibited a normal karyotype, and could generate all three germ layers. This 
cell line expressed the red fluorescence protein mCherry upon the induction of mesoderm differentiation. This reporter cell line could be used to monitor mesodermal 
population enrichment during mesodermal differentiation.   
Resource Table:  
Unique stem cell line 
identifier 
SNUe003-A-2 
Alternative name(s) of 
stem cell line 
B-mC-KI-SE-3, SNUe003-A-2 
Institution Seoul National University, Medical Research Center 
(MRC), Institute of Reproductive Medicine and 
Population (IRMP) 
Contact information of 
distributor 
Jong Kwan Jun, jhs0927@snu.ac.kr 
Jiho Jang, jhjang@cku.ac.kr 
Type of cell line ESC 
Origin Human 
Additional origin info Sex: Male 
Ethnicity: Korean 
Cell Source SNUhES3 human embryonic stem cell 
Method of reprogramming N/A 
Genetic Modification Yes 
Type of Modification Reporter knock-in 
Associated disease N/A 
Gene/locus Brachyury/6q27 
Method of modification CRISPR/Cas9 
Name of transgene or 
resistance 
T2A-mCherry-polyA-PGK-NeoR-polyA 




Constitutive Neomycin resistant gene 
Date archived/stock date 2019/12 
Cell line repository/bank https://hpscreg.eu/cell-line/SNUe003-A-2, Seoul 
National University, MRC, IRMP http://www.stemcell 
korea.org 
Ethical approval All research procedures involving hESCs were 
approved by the Institutional Review Board (IRB) of 
Seoul National University, MRC, IRMP (approval no. 
219932-201904-04-01-01)   
1. Resource utility 
The Brachyury-mCherry knock-in (KI) reporter human pluripotetnt 
stem cell (hPSC) line can be used to monitor the expression of Brachyury 
and assess mesodermal cell-type enrichment during mesodermal dif-
ferentiation. Thus, it can be used to develop culture conditions to effi-
ciently induce the enrichment of mesodermal cells. 
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2. Resource Details 
Brachyury is an embryonic nuclear transcription factor that binds to 
a specific DNA element, the palindromic T-site called the T-box, and it is 
necessary for mesoderm formation and differentiation (Knezevic et al., 
1997). Variations in this gene are associated with susceptibilities to 
defective neural tube closure and chordoma (Zhu et al., 2016). Here, we 
report the generation and characterization of a Brachyury-mCherry re-
porter hPSC line using a CRISPR/Cas9-mediated knock-in (KI) system 
(Table 1). 
First, the correct clones were chosen based on G418 resistance after 
electroporation with the Brachyury KI donor vector and Cas9/sgRNA 
plasmids. The donor construct comprised an mCherry reporter, NeoR 
marker, and two homology arm sequences (Fig. 1A). A single guide RNA 
(sgRNA) was designed to target the stop codon region of the Brachyury 
gene. Next, properly targeted clones were validated by a PCR screening 
strategy using specific primer sets located outside each homology arm, 
respectively (LA-F/R and RA-F/R), and a KI-F/R primer set located at 
each homology arm, which showed that the BRACHYURY #2–12 clone 
was mono-allelically inserted (Fig. S1). Finally, DNA sequencing 
ensured that the KI gene cassette was incorporated in frame downstream 
of endogenous BRACHYURY (Fig. 1B). 
Brachyury-mCherry hPSCs showed a normal karyotype (46, XY) at 
passage 46 (Fig. 1C) and no mycoplasma contamination (Fig. S2). 
SNUe003-A-2 cells exhibited typical human pluripotent stem cell-like 
morphology and alkaline phosphatase (AP) activity (Fig. 1D). The plu-
ripotency of SNUe003-A-2 hPSCs was confirmed by immunostaining 
using pluripotency markers (OCT4, SSEA-4, TRA-1–60, and TRA-1–81) 
(Fig. 1E) and also by RT-PCR for pluripotency genes (NANOG, SOX2, 
REX1, OCT4, and TERT) (Fig. 1F). This cell line had the potential to 
differentiate into all three germ layers, the endoderm (Alpha-Fetopro-
tein (AFP) and HNF3β), mesoderm (Enolase and Brachyury), and ecto-
derm (Nestin, Vimentin, and MAP2) (Fig. 1G). 
The expression of endogenous mCherry was observed from day 2 of 
mesoderm differentiation (Fig. 1H). To augment the mCherry speci-
ficity, we confirmed the clear co-localization of BRACHYURY and 
mCherry by immunostaining (Fig. 1I). To enable independent produc-
tion of Brachyury and mCherry polypeptides, a self-cleaving 2A (T2A) 
site was placed between the 5′ homology arm and the mCherry cassette, 
and mCherry expression was regulated by the endogenous Brachyury 
promoter. We thus checked the mesodermal sublineage differentiation 
potential of the parental and SNUe003-A-2 cell line by inducing the 
differentiation of two cell lines into cardiomyocytes and endothelial 
cells (ECs). The beating characteristics and the expression of the cardiac- 
specific marker cardiac troponin T (cTnT) in cardiac clusters derived 
from SNUe003-A-2 hPSCs were observed comparably to those in the 
parental hPSCs after day 8 ~ 12 of cardiac differentiation (Fig. S3and 
1J). Furthermore, SNUe003-A-2 hPSCs displayed the expression of CD31 
and Von Willebrand factor (vWF), endothelial lineage markers and a 
mature EC marker, similarly to those in the parental hPSCs at day 8 ~ 10 
of differentiation (Fig. 1K). Together, these data suggest that the fusion 
of a 2A non-joining peptide barely affected the mesodermal sublineage 
differentiation potential. 
3. Materials and methods 
3.1. Cell culture 
Undifferentiated hPSCs (SNUhES3) were maintained on vitronectin- 
coated plates in Essential 8 media (Gibco) without feeders. For single 
cell culture, the cells were passaged weekly in Essential 8 medium 
containing Y-27632 using accutase, following a split ratio of 1 to 40. 
3.2. Generation of Brachyury-mCherry KI reporter cell line 
The SNUhES3 hESC line was used to generate the Brachyury- 
mCherry reporter hESC line. First, 2 × 105 cells/ml were transfected 
with a donor construct, Cas9 (Type II-A Streptococcus pyogenes Cas9, 
ToolGen), and sgRNA plasmid (ToolGen) using the Neon transfection 
system (Thermo Fisher Scientific). Following electroporation, the 
transfected cells were plated on vitronectin-coated plates in E8 medium 
containing Y-27632. After day 4, the cells were treated with G418 
(Calbiochem) increasing sequentially from 50 µg/ml to 100 µg/ml. After 
drug selection, G418-resistant clones were individually picked and 
expanded. To confirm Brachyury-mCherry KI colonies, genomic DNA 
was extracted using the DNeasy Blood & Tissue Kit (Qiagen), and PCR 
was performed using the EmeraldAmp® GT PCR Master Mix (TAKARA 
Bio Inc.) and TaKaRa LA Taq® DNA polymerase (TAKARA Bio Inc.). The 
primers used are listed in Table 2. 
3.3. In vitro differentiation into three germ layers 
For the formation of embryoid bodies, hPSC colonies were harvested 
after 2 mg/ml collagenase IV (Gibco) treatment for 3 min and grown in 
suspension culture on low attachment Petri dishes with differentiation 
medium (TeSR™-E6™ medium) for 2 weeks. The culture medium was 
changed every other day. 
3.4. Cardiomyocyte and EC differentiation 
For cardiomyocyte differentiation, we employed a protocol using the 
PSC Cardiomyocyte Differentiation kit (Gibco) with slight modifica-
tions. Brachyury expression was observed using a fluorescence micro-
scope from day 2 to day 12. For EC differentiation from hPSCs, we used a 
previously described protocol with slight modifications (Harding et al., 
2017). On day 8 ~ 10 of differentiation, CD31 and vWF were observed 
Table 1 
Characterization and validation.  
Classification Test Result Data 
Morphology Photography Normal Fig. 1 panel 
DF 





Oct4, SSEA4, Tra- 
1–60, Tra-1–81, AP 
Fig. 1 panel 







REX1, OCT4, TERT 
Fig. 1 panel 
F 
Genotype Karyotype (G-banding) 
and resolution 
46,XY Fig. 1 panel 
C 
Identity Microsatellite PCR 
(mPCR) OR 
Not performed N/A 
STR analysis 16 STR loci were 







Sequencing heterozygous Fig. 1 panel 
B 






















HIV 1 + 2 Hepatitis B, 
Hepatitis C 






Not performed N/A 
HLA tissue typing Not performed N/A  
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using a fluorescence microscope (Olympus FSX 100 system). 
3.5. Reverse transcription PCR analysis 
Total RNA was isolated from generated cells using the Rneasy Mini 
kit (Qiagen), and cDNA was synthesized by reverse transcription PCR. 
The primers used to detect gene expression are listed in Table 2. 
3.6. Immunocytochemistry 
Cells were fixed with 4% paraformaldehyde for 30 min and then 
permeabilized overnight at 4 ◦C with 0.01% Tween 20, 3% BSA (1:1) 
blocking solution. The permeabilized cells were incubated overnight at 
4 ◦C with primary antibodies diluted in a 1% Triton X-100, 1% BSA 
solution. After three washes with dPBS, cells were incubated with sec-
ondary antibodies in a 1% Triton X-100, 1% BSA solution for 1 h at room 
temperature. Cells were washed five times and mounted with DAPI 
mounting medium (Vector Laboratories). Cell images were acquired 
with a fluorescence microscope. The antibodies used are listed in 
Table 2. 
3.7. Karyotyping and STR analysis 
The karyotype was analyzed following standard protocols for GTG 
banding. STR analysis for SNUe003-A-2 and parental cells was per-
formed by the DowGene (Korea). 
3.8. Mycoplasma testing 
Mycoplasma contamination was tested using an e-MycoTM Myco-
plasma PCR Detection kit (iNtRON Biotechnology, INC.), as per the 
manufacturer’s instructions. 
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Table 2 
Reagents details.  
Antibodies used for immunocytochemistry/flow-citometry  







































Santa Cruz Biotechnology, 
Cat#sc-20109, RRID: 
AB_2255702 
R&D Systems, Cat# 
MAB1874, RRID: 
AB_2206731 
BD Biosciences, Cat# 
550274, RRID:AB_393571 




lexa Fluor 488 
donkey anti- 
rabbit IgG (H +
L) 
1:200 Thermo Fisher Scientific, 
Cat#A21206, RRID: 
AB_2535792 
Alexa Fluor 594 
donkey anti- 
rabbit IgG (H +
L) 
1:200 Thermo Fisher Scientific, 
Cat#A21207, RRID: 
AB_141637 
Alexa Fluor 488 
donkey anti- 
mouse IgG (H +
L) 




Target Forward/Reverse primer (5′-3′) 




LA (1.4 kb) CATGCTAGCACACCTATG/ 
GACAGCTTCAAGTAGTCG 









NANOG (370 bp) CTGAGATGCCTCACACGGAGACTG/ 
GTCACACCATTGCTATTCTTC 
SOX2 (396 bp) GGCAGCTACAGCATGATGCAG/ 
GCTCTGGTAGTGCTGGGACATG 
REX1 (306 bp) GCGTACGCAAATTAAAGTCCAGA/ 
CAGCATCCTAAACAGCTCGCAGAAT 
OCT4 (219 bp) CTACAACGCCTACGAGTCCTACA/ 
TTCTGGCGCCGGTTACAGAACCA 






(AFP) (676 bp) 
AGAACCTGTCACAAGCTGTG/ 
GACAGCAAGCTGAGGATGTC 
HNF3b (196 bp) CCATTGCTGTTGTTGCAGGGAAGT/ 
CACCGTGTCAAGATTGGGAATGCT 












MAP2 (202 bp) GCATATGCGCTGATTCTTCA/ 
CTTTCCGTTCATCTGCCATT  
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